SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-014649
Filing Date
2024-05-28
Accepted
2024-05-28 16:10:22
Documents
1
Period of Report
2024-05-23

Document Format Files

Seq Description Document Type Size
1 form4-05282024_040517.html 4  
1 form4-05282024_040517.xml 4 4213
  Complete submission text file 0001415889-24-014649.txt   5693
Mailing Address C/O CRISPR THERAPEUTICS AG 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Lundberg Sven Ante (Reporting) CIK: 0001682126 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39979 | Film No.: 24991878

Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Issuer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)